Skip to content

Comparison of an Isotonic Balanced Fluid, Sterofundin® , With 0.9% Saline in Traumatic Brain Injury(TBI)

Comparison of an Isotonic Balanced Fluid, Sterofundin® , With 0.9% Saline in Traumatic Brain Injury(TBI)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02866604
Acronym
FLUID
Enrollment
160
Registered
2016-08-15
Start date
2016-10-31
Completion date
2019-02-28
Last updated
2016-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries

Keywords

Traumatic brain injury, isotonic balanced fluid

Brief summary

The main objective of this study is to compare the clinical outcomes of TBI patients receiving only Sterofundin or 0.9% saline as main fluid therapy.

Detailed description

Study Design: Prospective single centre double-blind randomized controlled trial Study endpoints/outcomes Primary outcomes: * 30 day mortality * Functional neurological outcomes at 6 months based on Extended Glasgow Outcome Scale (GOS-E) Secondary outcomes: * Acid-base and electrolyte balance * Daily mean change in intracranial pressure (ICP) * Episodes of intracranial hypertension * Duration of mechanical ventilation * Length of ICU stay and ICU mortality Study Duration: 2 years Site: UMMC. Departments involved: Emergency Medicine, Surgery, Anaesthesiology and Pharmacy Methodology. Investigators will assess patients admitted to the Emergency Department, UMMC, for eligibility. Randomisation: Investigators will randomize patients in a 1:1 ratio to either 0.9% saline intravenous fluid group or Sterofundin® intravenous fluid group. An independent statistician not involved with the research will perform a block of eight randomisation using computerised number generator list. Conduct of study The Department of Pharmacy will identically seal all 0.9% saline and Sterofundin® intravenous fluid bottles and label them, according to their type, as either A or B. The patients, investigators and medical and nursing staff will not be aware of the designation of the letters A and B to the fluids. Investigators will administer the study fluid will immediately after patient randomisation and this will last for 72 hours. Other general care of the traumatic brain injury patients from both study arms will continue as per Neurosurgical Unit protocol and Brain Trauma Foundation guidelines. Data handling Investigators will collect all data relevant to both primary and secondary outcomes (see also attached proforma): Statistical analysis Investigators will conduct students t test, Chi squared and the Mann-Whitney U test as appropriate. Investigators will adjust results with univariable and multivariable logistic regression and report their odds ratio. Investigators will present survival analysis using Kaplan Meier curves and compare them using log rank test.

Interventions

PROCEDURESterofundin
PROCEDURE0.9% saline

Sponsors

University of Malaya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients age between 18 and 65 years of age * Non-penetrating moderate (GCS 9-12) or severe (GCS 3-8) traumatic brain injury * Within 12 hours since the recorded time of injury

Exclusion criteria

* Pregnancy * Polytrauma * Cardiac arrest at presentation * GCS of three with bilateral fixed dilated pupils, * Evidence of severe cardiac, respiratory, renal or liver dysfunction

Design outcomes

Primary

MeasureTime frame
30 day mortality30 days
Functional neurological outcomes at 6 months based on Extended Glasgow Outcome Scale (GOS-E)180 days

Secondary

MeasureTime frameDescription
Episodes of intracranial hypertension3 daysthrough out intervention period
Duration of mechanical ventilation3 daysthrough out intervention period
Acid-base balance3 daysthrough out intervention period
electrolyte balance3 days
ICU mortality30 days
Length of ICU stay30 daysthrough out intervention period
Daily mean change in intracranial pressure (ICP)3 daysthrough out intervention period

Countries

Malaysia

Contacts

Primary ContactSia S Fu, MSurg, PhD
sfsia02@um.edu.my+603-79492441

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026